238 related articles for article (PubMed ID: 6345714)
1. Antibodies to normal human melanocytes in vitiligo.
Naughton GK; Eisinger M; Bystryn JC
J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.
Naughton GK; Eisinger M; Bystryn JC
J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis.
Howanitz N; Nordlund JL; Lerner AB; Bystryn JC
Arch Dermatol; 1981 Nov; 117(11):705-8. PubMed ID: 7316530
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibodies to melanocytes in vitiligo by western immunoblotting.
Hann SK; Shin HK; Park SH; Reynolds SR; Bystryn JC
Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487
[TBL] [Abstract][Full Text] [Related]
5. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
Cui J; Bystryn JC
Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
[TBL] [Abstract][Full Text] [Related]
7. Expression of vitiligo antigen on a revertant line of hamster melanoma cells.
Naughton GK; Lipkin G; Bystryn JC
J Invest Dermatol; 1984 Nov; 83(5):317-9. PubMed ID: 6386993
[TBL] [Abstract][Full Text] [Related]
8. Complement-fixing activity to melanin-producing cells preceding the onset of vitiligo in a patient with type 1 polyglandular failure.
Betterle C; Caretto A; Pedini B; Rigon F; Bertoli P; Peserico A
Arch Dermatol; 1992 Jan; 128(1):123-4. PubMed ID: 1739282
[No Abstract] [Full Text] [Related]
9. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
10. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
Garbelli S; Mantovani S; Palermo B; Giachino C
Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
[TBL] [Abstract][Full Text] [Related]
11. Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo.
Galbraith GM; Miller D; Emerson DL
Clin Immunol Immunopathol; 1988 Sep; 48(3):317-24. PubMed ID: 3042212
[TBL] [Abstract][Full Text] [Related]
12. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
Li YL; Yu CL; Yu HS
J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
[TBL] [Abstract][Full Text] [Related]
13. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.
Park YK; Kim NS; Hann SK; Im S
J Dermatol Sci; 1996 Feb; 11(2):111-20. PubMed ID: 8869031
[TBL] [Abstract][Full Text] [Related]
14. Characterization of vitiligo antigens.
Cui J; Arita Y; Bystryn JC
Pigment Cell Res; 1995 Feb; 8(1):53-9. PubMed ID: 7792255
[TBL] [Abstract][Full Text] [Related]
15. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to surface antigens of pigmented cells in animals with vitiligo.
Naughton GK; Mahaffey M; Bystryn JC
Proc Soc Exp Biol Med; 1986 Mar; 181(3):423-6. PubMed ID: 3511476
[TBL] [Abstract][Full Text] [Related]
17. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.
Ogg GS; Rod Dunbar P; Romero P; Chen JL; Cerundolo V
J Exp Med; 1998 Sep; 188(6):1203-8. PubMed ID: 9743539
[TBL] [Abstract][Full Text] [Related]
18. Cytolytic antibodies to melanocytes in vitiligo.
Cui J; Arita Y; Bystryn JC
J Invest Dermatol; 1993 Jun; 100(6):812-5. PubMed ID: 8496621
[TBL] [Abstract][Full Text] [Related]
19. [Detection of antibodies to melanoma cells in vitiligo by 125I-labeled SpA antibody binding assay].
Mori N; Shimada K; Satoh N; Nagao S; Iijima S; Kanzaki T
Nihon Hifuka Gakkai Zasshi; 1986 Jul; 96(8):835-8. PubMed ID: 3784053
[No Abstract] [Full Text] [Related]
20. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
Chen JP; Li HP; Jin SH; Zhang JT; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2107-8, 2111. PubMed ID: 19861278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
